These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 22492959)

  • 1. Insights into pediatric diffuse intrinsic pontine glioma through proteomic analysis of cerebrospinal fluid.
    Saratsis AM; Yadavilli S; Magge S; Rood BR; Perez J; Hill DA; Hwang E; Kilburn L; Packer RJ; Nazarian J
    Neuro Oncol; 2012 May; 14(5):547-60. PubMed ID: 22492959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative multidimensional molecular analyses of pediatric diffuse intrinsic pontine glioma reveals distinct molecular subtypes.
    Saratsis AM; Kambhampati M; Snyder K; Yadavilli S; Devaney JM; Harmon B; Hall J; Raabe EH; An P; Weingart M; Rood BR; Magge SN; MacDonald TJ; Packer RJ; Nazarian J
    Acta Neuropathol; 2014; 127(6):881-95. PubMed ID: 24297113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tenascin-C expression contributes to pediatric brainstem glioma tumor phenotype and represents a novel biomarker of disease.
    Qi J; Esfahani DR; Huang T; Ozark P; Bartom E; Hashizume R; Bonner ER; An S; Horbinski CM; James CD; Saratsis AM
    Acta Neuropathol Commun; 2019 May; 7(1):75. PubMed ID: 31092287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma.
    Huang TY; Piunti A; Lulla RR; Qi J; Horbinski CM; Tomita T; James CD; Shilatifard A; Saratsis AM
    Acta Neuropathol Commun; 2017 Apr; 5(1):28. PubMed ID: 28416018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy.
    Lieberman NAP; DeGolier K; Kovar HM; Davis A; Hoglund V; Stevens J; Winter C; Deutsch G; Furlan SN; Vitanza NA; Leary SES; Crane CA
    Neuro Oncol; 2019 Jan; 21(1):83-94. PubMed ID: 30169876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas.
    Dorris K; Sobo M; Onar-Thomas A; Panditharatna E; Stevenson CB; Gardner SL; Dewire MD; Pierson CR; Olshefski R; Rempel SA; Goldman S; Miles L; Fouladi M; Drissi R
    J Neurooncol; 2014 Mar; 117(1):67-76. PubMed ID: 24477622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Expression of Wilms' Tumor Protein in Diffuse Intrinsic Pontine Glioma.
    Lee S; Kambhampati M; Yadavilli S; Gordish-Dressman H; Santi M; Cruz CR; Packer RJ; Almira-Suarez MI; Hwang EI; Nazarian J
    J Neuropathol Exp Neurol; 2019 May; 78(5):380-388. PubMed ID: 30990879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
    Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
    J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A standardized autopsy procurement allows for the comprehensive study of DIPG biology.
    Kambhampati M; Perez JP; Yadavilli S; Saratsis AM; Hill AD; Ho CY; Panditharatna E; Markel M; Packer RJ; Nazarian J
    Oncotarget; 2015 May; 6(14):12740-7. PubMed ID: 25749048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B7-H3, a potential therapeutic target, is expressed in diffuse intrinsic pontine glioma.
    Zhou Z; Luther N; Ibrahim GM; Hawkins C; Vibhakar R; Handler MH; Souweidane MM
    J Neurooncol; 2013 Feb; 111(3):257-64. PubMed ID: 23232807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A twenty-year review of diagnosing and treating children with diffuse intrinsic pontine glioma in The Netherlands.
    Veldhuijzen van Zanten SE; Jansen MH; Sanchez Aliaga E; van Vuurden DG; Vandertop WP; Kaspers GJ
    Expert Rev Anticancer Ther; 2015 Feb; 15(2):157-64. PubMed ID: 25435089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurements of the pons as a biomarker of progression for pediatric DIPG.
    Steffen-Smith EA; Baker EH; Venzon D; Shandilya S; Bent RS; Warren KE
    J Neurooncol; 2014 Jan; 116(1):127-33. PubMed ID: 24113877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transcription factor Olig2 is important for the biology of diffuse intrinsic pontine gliomas.
    Anderson JL; Muraleedharan R; Oatman N; Klotter A; Sengupta S; Waclaw RR; Wu J; Drissi R; Miles L; Raabe EH; Weirauch ML; Fouladi M; Chow LM; Hoffman L; DeWire M; Dasgupta B
    Neuro Oncol; 2017 Aug; 19(8):1068-1078. PubMed ID: 28339768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The international diffuse intrinsic pontine glioma registry: an infrastructure to accelerate collaborative research for an orphan disease.
    Baugh J; Bartels U; Leach J; Jones B; Chaney B; Warren KE; Kirkendall J; Doughman R; Hawkins C; Miles L; Fuller C; Hassall T; Bouffet E; Lane A; Hargrave D; Grill J; Hoffman LM; Jones C; Towbin A; Savage SA; Monje M; Li XN; Ziegler DS; Veldhuijzen van Zanten S; Kramm CM; van Vuurden DG; Fouladi M
    J Neurooncol; 2017 Apr; 132(2):323-331. PubMed ID: 28093680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG Registry.
    Gits HC; Anderson M; Stallard S; Pratt D; Zon B; Howell C; Kumar-Sinha C; Vats P; Kasaian K; Polan D; Matuszak M; Spratt DE; Leonard M; Qin T; Zhao L; Leach J; Chaney B; Escorza NY; Hendershot J; Jones B; Fuller C; Leary S; Bartels U; Bouffet E; Yock TI; Robertson P; Mody R; Venneti S; Chinnaiyan AM; Fouladi M; Gottardo NG; Koschmann C
    Acta Neuropathol Commun; 2018 Jul; 6(1):67. PubMed ID: 30049282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased natural killer cells in diffuse intrinsic pontine glioma patients.
    Zhang L; Yu H; Xue Y; Liu Y
    Childs Nerv Syst; 2020 Jul; 36(7):1345-1346. PubMed ID: 32418048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical evaluation of dasatinib alone and in combination with cabozantinib for the treatment of diffuse intrinsic pontine glioma.
    Truffaux N; Philippe C; Paulsson J; Andreiuolo F; Guerrini-Rousseau L; Cornilleau G; Le Dret L; Richon C; Lacroix L; Puget S; Geoerger B; Vassal G; Östman A; Grill J
    Neuro Oncol; 2015 Jul; 17(7):953-64. PubMed ID: 25534822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signal Transduction in Diffuse Intrinsic Pontine Glioma.
    Duchatel RJ; Jackson ER; Alvaro F; Nixon B; Hondermarck H; Dun MD
    Proteomics; 2019 Nov; 19(21-22):e1800479. PubMed ID: 31328874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries.
    Hoffman LM; Veldhuijzen van Zanten SEM; Colditz N; Baugh J; Chaney B; Hoffmann M; Lane A; Fuller C; Miles L; Hawkins C; Bartels U; Bouffet E; Goldman S; Leary S; Foreman NK; Packer R; Warren KE; Broniscer A; Kieran MW; Minturn J; Comito M; Broxson E; Shih CS; Khatua S; Chintagumpala M; Carret AS; Escorza NY; Hassall T; Ziegler DS; Gottardo N; Dholaria H; Doughman R; Benesch M; Drissi R; Nazarian J; Jabado N; Boddaert N; Varlet P; Giraud G; Castel D; Puget S; Jones C; Hulleman E; Modena P; Giagnacovo M; Antonelli M; Pietsch T; Gielen GH; Jones DTW; Sturm D; Pfister SM; Gerber NU; Grotzer MA; Pfaff E; von Bueren AO; Hargrave D; Solanki GA; Jadrijevic Cvrlje F; Kaspers GJL; Vandertop WP; Grill J; Bailey S; Biassoni V; Massimino M; Calmon R; Sanchez E; Bison B; Warmuth-Metz M; Leach J; Jones B; van Vuurden DG; Kramm CM; Fouladi M
    J Clin Oncol; 2018 Jul; 36(19):1963-1972. PubMed ID: 29746225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria.
    Jansen MH; Veldhuijzen van Zanten SE; Sanchez Aliaga E; Heymans MW; Warmuth-Metz M; Hargrave D; van der Hoeven EJ; Gidding CE; de Bont ES; Eshghi OS; Reddingius R; Peeters CM; Schouten-van Meeteren AY; Gooskens RH; Granzen B; Paardekooper GM; Janssens GO; Noske DP; Barkhof F; Kramm CM; Vandertop WP; Kaspers GJ; van Vuurden DG
    Neuro Oncol; 2015 Jan; 17(1):160-6. PubMed ID: 24903904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.